Xiaowei Ren

ORCID: 0000-0002-8316-2755 · 4 papers in corpus
rct 2024
F&S reports ·doi:10.1016/j.xfre.2024.03.002

OBJECTIVE: To evaluate the efficacy and safety of 2 doses of vilaprisan vs. placebo in participants with symptomatic endometriosis. DESIGN: Multicenter, randomized, double-blind, placebo-controlled, parallel-group phase 2b trial (NCT035733…

rct 2019
Journal of women's health (2002) ·doi:10.1089/jwh.2018.7084

BACKGROUND: Dienogest provided significantly greater reduction in endometriosis-associated pelvic pain (EAPP) than placebo in a 24-week, randomized, double-blind study of Chinese women with endometriosis. The current open-label extension st…

observational 2018
International journal of environmental research and public health ·doi:10.3390/ijerph15112444

The aim of this study was to investigate the association between female reproductive status and risk of spontaneous abortion among female workers in the Jinchang Cohort. This study used data obtained from a baseline survey of the Jinchang C…

rct 2017
Journal of women's health (2002) ·doi:10.1089/jwh.2017.6399

BACKGROUND: Dienogest is a progestin with demonstrated efficacy in the treatment of endometriosis in European women. The objective of this study was to evaluate the efficacy and safety of dienogest in Chinese women. PATIENTS AND METHODS: T…